Brief: Immuneering Reports Third Quarter Results
Nov 10 (Reuters) - Immuneering Corp IMRX.O :
* IMMUNEERING REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
AND
RECENT BUSINESS HIGHLIGHTS
* Q3 LOSS PER SHARE $0.49
* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF
$117.2M AT
QUARTER END, EXPECTED TO PROVIDE CASH RUNWAY INTO Q3 2024
* Q3 EARNINGS PER SHARE VIEW $-0.49 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbNJXJ7
Further company coverage: IMRX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Immuneering
See all newsImmuneering expects cash runway to fund operations into 2029
Immuneering posts smaller-than-expected Q1 net loss on lower R&D spend
U.S. STOCKS ON THE MOVE-GoPro, Prudential Financial, Whitestone REIT
U.S. STOCKS ON THE MOVE-US airlines, BlackRock, copper miners
U.S. STOCKS ON THE MOVE-Gap, Caterpillar, Solid Biosciences